Cryoablation for Advanced and Refractory Desmoid Tumors

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

30 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-07

Study Completion Date

2023-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Desmoid tumors, also called aggressive fibromatosis, are rare, locally invasive tumors with no potential for metastasis. The incidence is approximately 2 to 4 per million per year in the general population. The "watch and wait" policy is the standard of care for newly diagnosed patients in Europe. Patients who progress have first-line medical treatment, surgery is no longer the treatment because there is a high rate of recurrence (\> 60%) and radiotherapy is not very suitable because the patients are often young and the tumors are large. Cryoablation seems to be an effective therapeutic option that should be evaluated.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cryoablation Versus Medical Therapy in Desmoid Tumors Progressing After Watchful Waiting

NCT06081400

Desmoid Tumor

RECRUITING NA

Cryotherapy in the Treatment of Desmoid Tumors

NCT05091255

Desmoid

RECRUITING NA

Quality of Life of Patients With Desmoid-type Fibromatosis

NCT04289077

Desmoid Tumor Desmoid-type Fibromatosis

COMPLETED

Radiomics Compared With Conventional Response Criteria for Predicting Progression of Desmoid Tumor After Cryoablation

NCT06224283

Desmoid

RECRUITING

Descriptive Study of a Cohort of Orbital Solitary Fibrous Tumors

NCT05613244

Orbital Tumor

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Desmoid Tumors

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adult patient (≥18 years old)
* Having undergone cryoablation for an advanced desmoid tumor refractory to medical treatment
* Having not expressed their opposition, after being informed, to the reuse of their data for the purposes of this research.

Exclusion Criteria

* Subject who expressed their opposition to participating in the study
* Patient already included in another ongoing study
* Subject under guardianship or curatorship
* Subject under safeguard of justice

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No